Laparoscopic abdominoperineal resection for

Agachan, Feran; Alabaz, Omer; Iroatulam, Augustine J.N.; Weiss, Eric G.; Nogueras, Juan J.; Wexner, Steven D.
January 1998
American Surgeon;Jan1998, Vol. 64 Issue 1, p12
Academic Journal
Evaluates the outcome of laparoscopic abdominoperineal resection (APR) in treating anorectal cancer. Methods utilized on the study; Short-term outcome of laparoscopic colorectal surgery; Feasibility of laparoscopic abdominoperineal resection; Discussion of the study's results.


Related Articles

  • Combined therapy improves outcome in anal cancer. Mertens, Stephan // BMJ: British Medical Journal (International Edition);10/26/96, Vol. 313 Issue 7064, p1035 

    Assesses the effectiveness of combined radiotherapy and chemotherapy in treating anal cancer. Clinical trials of the combined therapy; Treatment potentials of adding cisplatin to the chemotherapy regimen.

  • Radiation oncology.  // Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS92 

    Presents an abstract of the research manuscript `Clinical control of an anal canal carcinoma: Role for a DT-diaphorase mutation/polymorphism?,' by Zelanna Goldberg et al.

  • Agreements/contracts.  // Medical Device Daily;7/19/2010, Vol. 14 Issue 138, p4 

    The article reports on the partnership of Integris Cancer Institute of Oklahoma and the ProCure Proton Therapy Center for a new treatment approach for anal canal cancer.

  • Smear test developed for anal cancer.  // Gastrointestinal Nursing;Nov2008, Vol. 6 Issue 9, p4 

    The article reports on the development of a smear test for anal cancer by the scientists in Cambridge, Massachusetts. The test is based on the fact that normal anal tissue lacks minichromosome maintenance proteins (MCMs). The MCM testing has the ability to detect anal cancer in 235 anal smears...

  • Anal canal cancer treatment: practical limitations of routine prescription of concurrent chemotherapy and radiotherapy. Chauveinc, L.; Buthaud, X.; Falcou, M.C.; Mosseri, V.; De la Rochefordi√®re, A.; Pierga, J.Y.; Girodet, J.; Salmon, R.J. // British Journal of Cancer;12/1/2003, Vol. 89 Issue 11, p2057 

    This study is an analysis of the criteria considered when prescribing concomitant chemotherapy and radiotherapy, as a routine treatment for patients with anal canal cancer, and related complications. Between 1990 and 1996, 67 patients were treated at Institut Curie for invasive, nonmetastatic...

  • Results of Surgical Salvage Treatment for Anal Canal Cancer: A Retrospective Analysis with Overview of the Literature. Pesi, Benedetta; Scaringi, Stefano; Di Martino, Carmela; Batignani, Giacomo; Giudici, Francesco; Bisogni, Damiano; Tonelli, Francesco; Bechi, Paolo // Digestive Surgery;Aug2017, Vol. 34 Issue 5, p380 

    Background and Aim: Chemoradiotherapy (CRT) is the gold standard treatment for anal cancer, which permits the maintenance of the anal function. However, about 30-40% of patients develop local disease progression, for which surgery represents a good salvage therapy. The aim of this study is to...

  • Research Roundup.  // Environmental Nutrition;Oct98, Vol. 21 Issue 10, p8 

    Offers tip on various health issues. Findings of a study from the University of Georgia in Athens, Georgia and the Centers for Disease Control and Prevention in Atlanta, Georgia, which supports the benefits of boning up on calcium for women with hearing loss; Suggestion that older adults with...

  • P40: Non-surgical treatment of squamous cell carcinoma of the anal canal. Majdoul, S.; Issara, K.; Mokhlissi, M.; Mansouri, S.; Tawfiq, N.; Bouchbika, Z.; Benchakroun, N.; Jouhadi, H.; Sahraoui, S.; Benider, A. // Clinical Cancer Investigation Journal;2015 Supplement, Vol. 4 Issue S1, pS34 

    Introduction: Squamous cell cancer of the anal canal is a rare tumor with loco-regional evolution often slow, its management is multidisciplinary. Methods: This is a retrospective study conducted at the Oncology Centre in Casablanca, collects 42 cases of patients treated for anal canal cancer...

  • Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option. Meulendijks, D; Dewit, L; Tomasoa, N B; van Tinteren, H; Beijnen, J H; Schellens, J H M; Cats, A // British Journal of Cancer;10/28/2014, Vol. 111 Issue 9, p1726 

    Background:Capecitabine is an established treatment alternative to intravenous 5-fluorouracil (5-FU) for patients with rectal cancer receiving chemoradiotherapy. Its place in the treatment of locally advanced anal carcinoma (AC), however, remains undetermined. We investigated whether...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics